Literature DB >> 24636722

The usefulness of the head-up tilt test in patients with suspected epilepsy.

Inês Rangel1, João Freitas2, Ana Sofia Correia2, Alexandra Sousa2, Ana Lebreiro2, Carla de Sousa2, Maria Júlia Maciel2, Elsa Azevedo3.   

Abstract

PURPOSE: It is estimated that approximately 20-30% of patients diagnosed with epilepsy have been misdiagnosed, and neurocardiogenic syncope (NCS) might frequently be the real cause of transient loss of consciousness (TLOC) episodes. We assessed the role of the head-up tilt test (HUTT) in patients previously diagnosed with refractory epilepsy to evaluate the ability of this test to correctly diagnose patients with NCS.
METHOD: We retrospectively analysed the clinical records of 107 consecutive patients with a previous diagnosis of refractory epilepsy that were taking antiepileptic drugs and who were referred for HUTT between January 2000 and December 2010. During the subsequent follow-up, we recorded the treatments performed and the recurrence of symptoms.
RESULTS: Complete follow-up data were available for 94 (88%) patients, and the mean follow-up period was 80±36 months. The HUTT was positive in 54% of patients. Thirty-one (33%) patients were misdiagnosed with epilepsy, and 20 (21%) patients had a dual diagnosis of NCS and epilepsy. The recurrence of TLOC was reported in 55% of the patients, but it was significantly lower in the misdiagnosed group (42% versus 64%; P=0.039).
CONCLUSION: NCS is an important cause of epilepsy misdiagnosis. The HUTT is often critical for making an accurate diagnosis and subsequently selecting the appropriate treatment for patients presenting with TLOC. The diagnostic overlap between epilepsy and NCS is not uncommon, suggesting that electroencephalographic monitoring during a HUTT may play an important role in diagnosing patients with recurrent, undiagnosed TLOC episodes.
Copyright © 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epilepsy; Head-up tilt test; Misdiagnosis; Neurocardiogenic syncope

Mesh:

Year:  2014        PMID: 24636722     DOI: 10.1016/j.seizure.2014.02.004

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

1.  Calgary score and modified Calgary score in the differential diagnosis between neurally mediated syncope and epilepsy in children.

Authors:  Runmei Zou; Shuo Wang; Liping Zhu; Lijia Wu; Ping Lin; Fang Li; Zhenwu Xie; Xiaohong Li; Cheng Wang
Journal:  Neurol Sci       Date:  2016-10-17       Impact factor: 3.307

Review 2.  Tilt table test today - state of the art.

Authors:  Nicholay Teodorovich; Moshe Swissa
Journal:  World J Cardiol       Date:  2016-03-26

3.  Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS).

Authors:  Andrea Ungar; Alice Ceccofiglio; Francesca Pescini; Chiara Mussi; Gianni Tava; Martina Rafanelli; Assunta Langellotto; Niccolò Marchionni; J Gert van Dijk; Gianlugi Galizia; Domenico Bonaduce; Pasquale Abete
Journal:  BMC Neurol       Date:  2017-02-28       Impact factor: 2.474

4.  Recurrent seizures in a young woman: when video-EEG diagnoses a cardiac cause: a case report.

Authors:  Corentin Chaumont; Julie Bourilhon; Nathalie Chastan; Adrian Mirolo; Hélène Eltchaninoff; Frédéric Anselme
Journal:  Eur Heart J Case Rep       Date:  2020-09-19

5.  Tilt testing remains a valuable asset.

Authors:  Richard Sutton; Artur Fedorowski; Brian Olshansky; J Gert van Dijk; Haruhiko Abe; Michele Brignole; Frederik de Lange; Rose Anne Kenny; Phang Boon Lim; Angel Moya; Stuart D Rosen; Vincenzo Russo; Julian M Stewart; Roland D Thijs; David G Benditt
Journal:  Eur Heart J       Date:  2021-05-01       Impact factor: 35.855

6.  Plasma brain-type natriuretic Peptide level following seizure and syncope: pilot study.

Authors:  Kyung-Il Park
Journal:  J Epilepsy Res       Date:  2014-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.